Join
Live feed
·
PRReleasevia Quantisnow
Ascendis Pharma A/S logo
Royalty Pharma plc logo

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASND (Ascendis Pharma A/S), RPRX (Royalty Pharma plc) and more on Quantisnow.